Ponoi Ii Management, LLC Nurix Therapeutics, Inc. Transaction History
Ponoi Ii Management, LLC
- $38.3 Million
- Q3 2022
A detailed history of Ponoi Ii Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Ponoi Ii Management, LLC holds 327,123 shares of NRIX stock, worth $5.57 Million. This represents 11.14% of its overall portfolio holdings.
Number of Shares
327,123
Previous 327,123
-0.0%
Holding current value
$5.57 Million
Previous $4.15 Million
2.82%
% of portfolio
11.14%
Previous 11.26%
Shares
3 transactions
Others Institutions Holding NRIX
# of Institutions
185Shares Held
70.6MCall Options Held
318KPut Options Held
42.4K-
Black Rock Inc. New York, NY6.82MShares$116 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$74 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.19MShares$71.4 Million6.18% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$66.2 Million0.81% of portfolio
-
Wellington Management Group LLP Boston, MA3.59MShares$61.1 Million0.01% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $803M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...